|Bid||237.60 x 800|
|Ask||237.64 x 800|
|Day's Range||236.21 - 243.01|
|52 Week Range||199.11 - 255.21|
|Beta (5Y Monthly)||1.04|
|PE Ratio (TTM)||29.23|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov 25, 1996|
|1y Target Est||N/A|
Waters Corporation (NYSE:WAT) announced today that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves the use of automation technology, enabling more scientists to realize the advantages of repeatability and performance for both routine and complex laboratory workflows.
Waters Corporation (NYSE:WAT) will webcast its Q4 2019 financial results conference call live on Tuesday, February 4th at 8:00 a.m. eastern time. To listen to the conference call connect to Waters’ website, www.waters.com choose "Investors" and click on the Live Webcast. A replay of the webcast will be available until February 11th at midnight eastern time.
Based on its analysis of the global biopharmaceutical analytical instrumentation market, Frost & Sullivan recognizes Waters Corporation with the 2019 Global New Product Innovation Award for its smart BioAccord Liquid Chromatography-Mass Spectrometry (LC-MS) System. It is the first smart MS-enabled biopharmaceutical solution with intelligent software and chemistries, which deliver high levels of reliability, sensitivity, and detection.
Waters Corporation (NYSE:WAT) Christopher J. O’Connell, Chairman and Chief Executive Officer, will speak to the investment community at the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Monday, January 13th, 2020 at 7:30 a.m. Pacific Time.
Waters Corporation (NYSE:WAT) today announced its 2025 sustainability goals and simultaneously announced a commitment to report its sustainability progress annually. These goals were developed following a comprehensive materiality assessment and are published in Waters’ latest sustainability report, which covers activities and progress from 2018 and key highlights from 2019.
Aston University and Waters Corporation (WAT) announced today the completed installation of the world’s first Waters™ SELECT SERIES™ Cyclic™ IMS (ion mobility spectrometry) mass spectrometer within the University’s School of Health and Life Sciences, where the instrument will support research into the biology of human diseases, the discovery of new therapeutics and advances in biotechnology. Mass spectrometry (MS) is a widely deployed analytical method used by scientists to identify and quantify molecules in a sample and determine their detailed molecular structure. Ion mobility spectrometry is a proven technique that separates ions by their size, shape and charge.
New Quaternary Solvent Manager Enables Polymer Chemists to Perform Analyses on a Single System that Conventionally Required Multiple Instruments and Retrofitting
BOSTON , Oct. 31, 2019 /PRNewswire/ -- TetraScience, developers of the industry's first cloud-based data integration platform for life sciences R&D, today announced it has secured a strategic investment ...
MILFORD, Mass.-- -- Sales of $577 million were flat as reported and grew 1% in constant currency Pharmaceutical growth of 3%, partially offset by other end markets Continued growth in Asia, with weakness in the Americas GAAP EPS of $2.07; non-GAAP EPS of $2.13, an 11% increase from prior year Waters Corporation today announced third quarter 2019 sales of $577 million, which were flat as reported, compared ...
Waters Corporation will webcast its Q3 2019 financial results conference call live on Tuesday, October 29th at 8:00 a.m. eastern time. To listen to the conference call connect to Waters’ website, www.waters.com choose “Investors” and click on the Live Webcast.
Waters Corporation (WAT) today introduced the new TA Instruments™ MSF16 Multi-Specimen Fatigue Instrument. Fatigue testing of component materials or final assemblies involves repetitive mechanical loading (stress and strains) that measure when and how they fail. TA’s MSF16 instrument, equipped with industry leading motor technology and 16-sample capacity, significantly accelerates fatigue analysis and provides users a competitive edge by reducing their time-to-market.
ZAGREB, Croatia and IPSWICH, Mass. and MILFORD, Mass., June 17, 2019 /PRNewswire/ -- The Human Glycome Project, Genos®, New England Biolabs® (NEB®) and Waters™ Corporation today announced a collaboration to accelerate glycomics research by providing goods and services critical to glycan analysis. Launched in October 2018, the Human Glycome Project is a global initiative to map the structure and function of human glycans. The completion of the human genome project opened multiple new opportunities to study and understand human health, but it also led to the realization that the genome is only one of the elements that controls life.
First-of-its-Kind Cyclic IMS Provides Unlimited Experimental Opportunities while the Research-Grade SYNAPT XS Brings Analytical Flexibility
Waters Corporation Chris O'Connell, Chairman and Chief Executive Officer, will speak to the investment community at the UBS Global Healthcare Conference to be held at the Grand Hyatt New York, Monday, May 20th at 2:00 PM eastern time.
MILFORD, Mass.-- -- Sales of $514 million declined 3% as reported and were flat in constant currency Recurring revenue growth offset by declines in instrument sales Growth in broader Asia and the U.S. offset by weakness in China and Europe GAAP EPS of $1.51; non-GAAP EPS of $1.60, a slight increase from prior year Waters Corporation today announced first quarter 2019 sales of $514 million, a 3% decrease ...
Waters Corporation will webcast its Q1 2019 financial results conference call live on Tuesday, April 23rd at 8:00 a.m. eastern time. To listen to the conference call connect to Waters’ website, www.waters.com choose “Investors” and click on the Live Webcast.
Waters Corporation (WAT) announced today Terry Kelly is stepping down as President of TA Instruments effective immediately. TA Instruments, based in New Castle, Delaware is a division of Waters specializing in thermal analysis, rheology and mechanical testing. Mr. Kelly will serve as a senior advisor for the next 90 days as he transitions to retirement.